Drug · DIN 02401347
ADCETRIS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 9, 2025; first marketed February 19, 2013.
- Drug Identification Number (DIN)
- 02401347
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Brentuximab vedotin L01FX05
- Class
- Human
- Record last updated
- November 24, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BRENTUXIMAB VEDOTIN | 50 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 11, 2021: NOC 26050New Drug Submission (NDS) · Manufacturer name change
- February 1, 2013: NOC 14056New Drug Submission (NDS)